Department of Otolaryngology, Taichung Veterans General Hospital, Taichung, Taiwan.
Am J Rhinol Allergy. 2011 May-Jun;25(3):170-5. doi: 10.2500/ajra.2011.25.3610.
A number of herbal preparations have been reported being used as adjunctive treatment of patients with chronic rhinosinusitis (CRS) after functional endoscopic sinus surgery (FESS). This study was designed to examine the efficacy of Chinese herbal medicine (CHM) in the postoperative care of post-FESS patients.
Patients with CRS who underwent FESS were prospectively enrolled in the study. Before surgery, they were evaluated by various methods, including the Chinese version of the Rhinosinusitis Outcome Measure (CRSOM-31), nasal endoscopy, acoustic rhinometry, and computed tomography (CT). After surgery, they were randomized to take CHM (Tsang-Erh-San extract granules and Houttuynia extract powder) for 8 weeks, amoxicillin for 4 weeks, or placebo. They were revaluated by CRSOM-31, nasal endoscopy, and acoustic rhinometry at 8 weeks and by CT at 12 weeks after surgery.
Ninety-seven patients (33 in the CHM group, 34 in the amoxicillin group, and 30 in the placebo group) completed the study. In the CHM group, CRSOM-31 and endoscopic scores significantly decreased, and the second minimal cross-sectional area of the nasal cavity measured by acoustic rhinometry significantly increased after treatment. In the amoxicillin and placebo groups, CRSOM-31, endoscopic, and CT scores significantly decreased after treatment. However, there were no significant differences in subjective and objective treatment outcomes among three groups of patients.
Our results showed there was no significant benefit of using CHMs (Tsang-Erh-San extract granules and Houttuynia extract powder) or oral amoxicillin in post-FESS care of CRS patients. Additional investigation is necessary for post-FESS care.
许多草药制剂已被报道作为功能性内窥镜鼻窦手术(FESS)后慢性鼻-鼻窦炎(CRS)患者的辅助治疗方法。本研究旨在探讨中药(CHM)在 FESS 术后患者护理中的疗效。
前瞻性纳入接受 FESS 的 CRS 患者。手术前,采用包括中文版鼻-鼻窦炎结局测量(CRSOM-31)、鼻内镜检查、声反射鼻测量和计算机断层扫描(CT)在内的各种方法对患者进行评估。手术后,患者被随机分为服用 CHM(苍耳子散和鱼腥草粉提取物颗粒)8 周、阿莫西林 4 周或安慰剂 8 周。在手术后 8 周和 12 周,通过 CRSOM-31、鼻内镜检查和声反射鼻测量进行再评估,并通过 CT 进行评估。
97 例患者(CHM 组 33 例,阿莫西林组 34 例,安慰剂组 30 例)完成了研究。在 CHM 组中,CRSOM-31 和内镜评分显著降低,声反射鼻测量的鼻腔第二最小横截面积显著增加。在阿莫西林和安慰剂组中,CRSOM-31、内镜和 CT 评分在治疗后显著降低。然而,三组患者的主观和客观治疗结果之间没有显著差异。
我们的结果表明,在 FESS 后 CRS 患者的护理中,使用 CHM(苍耳子散和鱼腥草粉提取物颗粒)或口服阿莫西林并没有显著获益。需要进一步研究 FESS 后护理。